ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Jin Xu
Matched on ORCID iD 0000-0001-6617-5311; OpenAlex author ID A5100782195. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2022: 2 papers · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- The CHPT-pSTAT3-SLC7A11 signaling axis controls progression and ferroptosis susceptibility of pancreatic cancer. Co-author DOI 10.1016/j.tranon.2025.102624↗
- A new approach: Evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatment targets in pancreatic cancer. Co-author DOI 10.1016/j.csbj.2023.03.037↗
- Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.tranon.2022.101561↗
- Turning towards nonimmunoreactive tumors: Evaluation of cancer-associated fibroblasts enables prediction of the immune microenvironment and treatment sensitivi… Co-author DOI 10.1016/j.csbj.2022.07.029↗
- Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer. Last author DOI 10.1186/s12920-022-01371-0↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Miaoyan Wei · 5 shared papers, 2022–2026 · strength 0.92
- Paper The CHPT-pSTAT3-SLC7A11 signaling axis controls progression and ferroptosis susceptibility of pancreatic cancer. DOI 10.1016/j.tranon.2025.102624↗
- Paper Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal ad… DOI 10.1016/j.tranon.2022.101561↗
- Paper A new approach: Evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatm… DOI 10.1016/j.csbj.2023.03.037↗
- Wei Wang · 5 shared papers, 2022–2026 · strength 0.92
- Paper The CHPT-pSTAT3-SLC7A11 signaling axis controls progression and ferroptosis susceptibility of pancreatic cancer. DOI 10.1016/j.tranon.2025.102624↗
- Paper Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal ad… DOI 10.1016/j.tranon.2022.101561↗
- Paper A new approach: Evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatm… DOI 10.1016/j.csbj.2023.03.037↗
- Xianjun Yu · 5 shared papers, 2022–2026 · strength 0.92
- Paper The CHPT-pSTAT3-SLC7A11 signaling axis controls progression and ferroptosis susceptibility of pancreatic cancer. DOI 10.1016/j.tranon.2025.102624↗
- Paper Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal ad… DOI 10.1016/j.tranon.2022.101561↗
- Paper A new approach: Evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatm… DOI 10.1016/j.csbj.2023.03.037↗
- Qingcai Meng · 4 shared papers, 2022–2026 · strength 0.74
- Paper The CHPT-pSTAT3-SLC7A11 signaling axis controls progression and ferroptosis susceptibility of pancreatic cancer. DOI 10.1016/j.tranon.2025.102624↗
- Paper A new approach: Evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatm… DOI 10.1016/j.csbj.2023.03.037↗
- Paper Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer. DOI 10.1186/s12920-022-01371-0↗
- Jie Hua · 4 shared papers, 2022–2026 · strength 0.74
- Paper The CHPT-pSTAT3-SLC7A11 signaling axis controls progression and ferroptosis susceptibility of pancreatic cancer. DOI 10.1016/j.tranon.2025.102624↗
- Paper A new approach: Evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatm… DOI 10.1016/j.csbj.2023.03.037↗
- Paper Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer. DOI 10.1186/s12920-022-01371-0↗
- Bo Zhang · 4 shared papers, 2022–2023 · strength 0.65
- Paper Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal ad… DOI 10.1016/j.tranon.2022.101561↗
- Paper A new approach: Evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatm… DOI 10.1016/j.csbj.2023.03.037↗
- Paper Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer. DOI 10.1186/s12920-022-01371-0↗
- Si Shi · 3 shared papers, 2022–2023 · strength 0.49
- Paper Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal ad… DOI 10.1016/j.tranon.2022.101561↗
- Paper A new approach: Evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatm… DOI 10.1016/j.csbj.2023.03.037↗
- Paper Turning towards nonimmunoreactive tumors: Evaluation of cancer-associated fibroblasts enables prediction of the immune … DOI 10.1016/j.csbj.2022.07.029↗
- Siyuan Lu · 3 shared papers, 2022–2023 · strength 0.47
- Paper A new approach: Evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatm… DOI 10.1016/j.csbj.2023.03.037↗
- Paper Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer. DOI 10.1186/s12920-022-01371-0↗
- Paper Turning towards nonimmunoreactive tumors: Evaluation of cancer-associated fibroblasts enables prediction of the immune … DOI 10.1016/j.csbj.2022.07.029↗
- Zhen Tan · 1 shared paper, 2026 · strength 0.27
- Jianhui Yang · 1 shared paper, 2026 · strength 0.27
- Chen Liang · 1 shared paper, 2026 · strength 0.27
- Zeyin Rong · 1 shared paper, 2026 · strength 0.27
- Xiaomeng Liu · 1 shared paper, 2023 · strength 0.18
- Jialin Li · 1 shared paper, 2023 · strength 0.18
- Hang Xu · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.